drugset / Trial / NCT01499056

Mesenchymal Stem Cell Transplantation in Osteoarthritis of Hip Joint

NCT01499056

Phase 1 Completed 6 enrolled Royan Institute
NaSingle-groupOpen-labelTreatment

Summary

Osteoarthritis of the hip is a common type of osteoarthritis which can cause significant problems. First-line of management for patient with osteoarthritis consists of weight reduction, education, and analgesic medication. If necessary, invasive treatment like total hip replacement are performed for the patient. The objective of this study was to assess the safety of bone marrow mesenchymal stem cells (BM-MSCs) implantation in patients with hip osteoarthritis

Timeline

Start
2010-06
Primary completion
2011-02
Completion
2011-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Mesenchymal stem cell Cell therapy Other

Indications